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Kawasaki disease (KD) or Kawasaki syndrome, an acute systemic vasculitis mainly developed 
in children younger than 5 years of age, may causes serious, life-threatening, cardiac sequelae 
including coronary artery aneurysm (CAA). Unfortunately, the disease-specific diagnostic 
tool of KD is lacking to date, and it has been a major obstacle to detect and treat the patients 
at the early stage and to prevent coronary artery lesions.
The cause of KD is largely unknown, but one of the most remarkable findings in its 
epidemiology is the distinct racial and familial tendency. Compared to the Western, the 
incidence rate in East Asian is 10 times higher.1) Also, from the data at Hawaii in 1996–2006, 
the incidence rate of white children was 13.7 per 100,000 children under 5 years old while 
that of Japanese children was 210.5, which is almost the same as that in mainland Japan. 
These data, which show very dramatic ethnic dominant pattern in KD, indicate that the 
different incidences between Western and East Asian are not caused by environmental or 
geographical factors, but by genetic disparity among ethnicities.2) On the other hand, the 
incidence in the family was reported to be 1.4–2.1%, which was more than 10-fold higher 
than in the general population, and especially with twins, reported 50- to 100-fold higher.3) 
These differences in racial and familial incidence strongly suggest that genetic factors play a 
major role in the development of KD.
Based on this background, to identify the genetic polymorphism associated with 
susceptibility to KD, numerous candidate genes related to immunologic or inflammatory 
reaction have been studied over 40 years. However, this kind of approaches failed to identify 
the definite disease loci because pathogenesis of KD is largely unknown. Therefore, several 
genome-wide association studies (GWASs) have been conducted worldwide (Table 1). 
Contrary to expectation, those results have not been consistent and the single-nucleotide 
polymorphisms that were found to be highly significant in one GWAS did not appear to be 
significant in other racial replication studies.4-6) The genetic factors associated with CAA, 
the most important long-term sequela of KD, have been studied in a few studies, but are not 
conclusive and have not yet been replicated in other study.
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► See the article “Assessment of the Clinical Heterogeneity of Kawasaki Disease Using Genetic 
Variants of BLK and FCGR2A” in volume 49 on page 99.
The ethnic differences in the polymorphism of KD-associated gene may have a role in the 
discrepancy of those results. In fact, a meta-analysis study demonstrated that there is a 
significant association between the H131R polymorphism of FCGR2A gene and KD risk in 
Asians, but not in Caucasians.7) On the other hand, the gender difference was reported in the 
polymorphism of KD-associated gene. In a meta-analysis with 1,461 cases and 5,302 controls, 
a very strong association of KD with the FCGR2A gene was confirmed in males, but not in 
the females.8) From these findings, we could infer that the heterogeneous variation of KD-
associated genes may contribute to the clinical and epidemiologic characteristics of KD.
Regarding the genetic heterogeneity in each KD patients, Sim et al.9) revealed a new finding 
that the genetic variations of related genes were associated with the diversity of clinical 
features in KD. KD is difficult to be diagnosed, because the number, timing, and duration of 
the clinical symptoms manifested in each patient are various, as to be referred to as Kawasaki 
syndrome. The authors provide a clue to this heterogeneity, analyzing the variations of BLK 
and FCGR2A gene that were identified in previous GWAS of KD patients and replicated in 
other population. In their results, the risk allele of BLK gene was strongly associated with 
complete KD in patients younger than 5 years, but not in patients with incomplete KD or 
older than 5 years old, and the risk allele of FCGR2A gene was strongly associated with only 
male patients younger than 1 year old. These findings suggest that the patients with the risk 
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Table 1. GWASs for KD
GWAS Replication
Population KD Control SNP Gene Function
European13) 119 135 rs1463525 NAALADL2 - −
rs2106261 ZFHX3 - −
rs7193343*
Taiwanese14) 250 446 rs1873668 COPB2 Regulation of T cell receptor signaling −
rs4243399
rs149481 ERAP1 M1 family of zinc metallopeptidases −
rs17113284 IGHV Immunoglobulin heavy chain variable region gene −
rs8005468
rs10129255
rs2007467
rs10150241
rs12590667
Korean15) 186 600 rs527409 DAB1 - −
rs7604693† PELI1 Negative regulation of T cell R signaling −
European16) 405 6,252 rs1801274 FCGR2A Fc gamma receptor gene +
rs2233152 MIA Growth inhibition on melanoma cells and 
neuroectodermal tumors
−
rs10403040 RAB4B Ras-related GTP-binding protein 4b gene 
(probably involved in vesicular traffic).
−
Japanese17) 428 3,379 rs2254546 FAM167A-BLK Involve in B-cell receptor signal transduction +
rs2857151 HLA-DQB2-HLA-DOB HLA region −
rs4813003 CD40 Increase translation efficiency of CD40 −
Taiwanese18) 622 1,107 rs2736340 BLK Involve in B-cell receptor signal transduction +
rs1883832 CD40 Reduce functionally null isoform of CD40 −
rs1569723
Taiwanese19),‡ 157 (11) - rs16921209† NEBL Binds to actin and involves in the assembly of the 
Z-disk of cardiac muscle
−
rs7922552†
rs17076896† TUBA3C Tubulin is a major constituent of microtubules −
Korean20),‡ 140 (17) - rs17136627† KCNN2 Calcium-activated potassium channel −
Numbers in parenthesis indicate KD patients with CAA.
CAA = coronary artery aneurysm; GTP = guanosine-5'-triphosphate; GWAS = genome-wide association study; HLA = human leukocyte antigen; KD = Kawasaki 
disease; SNP = single nucleiotide polymorphism.
*rs7193343 was associated with protective effect on the risk for KD; †Risk loci associated with coronary artery lesion or aneurysm in patients with KD; ‡GWAS 
conducted to identify susceptibility genes associated with CAA in KD, the data from KD patients with CAA were compared to the data from KD patients without CAA.
allele of BLK could develop the KD at a younger age and fully manifest, showing typical KD 
features. Also, it could be suggested that the risk allele of FCGR2A encoding high-affinity Fc 
gamma receptor that binds to the immunoglobulin G (IgG), could affect the development 
of KD in infants, who show the rare incidence of KD with the hypothesis that passive 
transmission of maternal IgG has a preventive effect on KD.
The large sample size is a strong point of Sim' study (1,011 cases and 4,553 controls).9) 
However, their results showed some discrepancies with previous reports on the clinical 
feature of KD. Although treated with immunoglobulin therapy, subjects showed very high 
incidence of coronary artery lesions (20.8%), and the infant patients showed the similar 
incidences of incomplete KD (7.6%) and coronary artery complication (15.2%) as the 
patients older than 1 year. It has been recognized that infants with KD have a high incidence 
of incomplete KD (45–67%) and coronary artery complication (30.8–64%).10-12) These 
discrepancies could be attributed to the selection bias in the sample collection, and their 
effect on the results is not clearly understood. Nevertheless, Sim's work presents new insight 
into understanding the pathogenetic mechanism of KD. Although much understanding 
has been accumulated about the clinical diversity of KD, there has been a little research on 
the relationship between genetic heterogeneity and clinical features, except polymorphism 
related to the coronary artery complication. Therefore, their result is very interesting that 
heterogeneity of associated genes is related to clinical features. I expect that this study will 
lead to a better understanding for overcoming of KD by triggering further studies on the 
genetic heterogeneity of KD and its impact. Although it is still the tip of the iceberg that we 
have revealed about KD, we hope successive new attempts in this kind will reveal the secret 
nature of KD in near future.
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